Medical Weight Loss for Mankato, Minnesota Residents

Mankato, Minnesota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Mankato through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Minnesota: there is no local Mankato office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Mankato Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Mankato, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across Minnesota for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

If you are searching for medical weight loss in Mankato, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

From the first visit to your refills, people in Mankato, Minnesota are cared for by Dr. Sharma through telehealth, so the only thing missing is the commute to Costa Mesa. We care for patients throughout downtown Mankato, the university area, and the greater Blue Earth County area. We bill the $119 physician visit clearly and keep your medication billed separately, so the cost is transparent before anything ships to Minnesota.

By handling visits through telehealth, we serve every neighborhood in Mankato, from downtown Mankato, the university area, and the greater Blue Earth County area, without asking anyone to travel. The $119 fee covers the physician review and visit itself; the medication, whether semaglutide from $166 a month or tirzepatide from $233, is a separate charge. Wherever you live in Minnesota, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic, with no travel required.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Mankato patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Mankato

Here is how the whole thing works, start to finish, for anyone in Mankato.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Mankato address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Mankato

I am searching for weight loss care near Mankato. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Mankato, Minnesota connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Mankato?

Not at all. The telehealth format covers Mankato patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Mankato in cold-pack packaging built to keep it cool and stable.

What are the program costs for Mankato patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Mankato patients face no distance surcharge.

What areas of Mankato do you serve?

We serve patients from across Mankato by telehealth, including downtown Mankato, the university area, and the greater Blue Earth County area.

How does telehealth treatment work for Mankato patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Mankato address. Follow-ups also happen by video.

Mankato Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Mankato, Minnesota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.